Rutgers Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment. People in the News: Peer Schatz Board Appointments at Siemens, Centogene; More E. Coli Metabolic Gene Mutations Implicated in Antibiotic Resistance The mutations in these underappreciated noncanonical genes were overrepresented in the E. coli genomes, indicating they were clinically relevant. Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions. Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management. Aug 19, 2020 Rutgers Completes $44.4M Spinout of RUCDR Infinite Biologics Jul 29, 2020 Saliva Samples Slow to Catch On for Large-Scale Coronavirus Testing Premium Apr 29, 2020 COVID-19 Testing Could Get Boost From Alternative Sample Types Premium Apr 20, 2020 Addressing Coronavirus Testing Bottleneck, Scientists Turn to RNA-Extraction-Free PCR Apr 13, 2020 Rutgers Gets FDA EUA for Modified Thermo Fisher Coronavirus Assay for Use With Saliva Samples Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Jan 14, 2020 Rutgers Licenses Base Editing Tech to Horizon Discovery Nov 4, 2019 RCSB Protein Data Bank Lands $34.5M in Federal Grants Oct 14, 2019 CureDuchenne, UC Irvine, RUCDR Partner on Muscular Dystrophy Biobank Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Jan 3, 2019 Tumor Sequencing May Pick Up Mutations Caused by Coexistent Blood Disorder Nov 29, 2018 2018 GenomeWeb Salary Survey Jan 29, 2018 Rutgers Statistical Method Assesses LOH in Tumor Suppressor Genes, Supplements Sequencing Panels Premium Jun 30, 2017 Team Modifies Molecular Inversion Probes to Capture Kilobase-Sized DNA for Cloning, Sequencing Premium May 3, 2017 Tourette Disorder Risk Linked to Variants in Four Genes Jan 26, 2017 Phylogenomic Study Shows Utility of Ancient DNA Samples for Modern Research Jan 14, 2016 UPDATE: NHGRI Pledges $280M to Support Genomic Research on Common, Rare Diseases Oct 22, 2015 New Study Finds Three More CRISPR Proteins With Genome Editing Potential Oct 21, 2015 RUCDR Infinite Biologics Awarded $6M Grant to Manage NINDS Stem Cell Repository Jul 16, 2015 RUCDR, PreAnalytix, NuGen Validate RNA-seq Workflow for Human Whole Blood Samples Premium Load More Breaking News Cytosine Base Editor Enables Genome-Wide Genetic Function Screening G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.